We are live on
!
Find out more
SCP
Sandhill Capital Partners Portfolio holdings
AUM
$1.16B
1-Year Est. Return
12.37%
This Fund
S&P 500
This Quarter
Est. Return
-14.17%
1 Year Est. Return
+12.37%
3 Year Est. Return
+56.48%
5 Year Est. Return
+73.2%
10 Year Est. Return
+460.75%
AUM
$935M
AUM Growth
-$228M
(-20%)
Cap. Flow
-$65.1M
Cap. Flow
% of AUM
-6.96%
Top 10 Holdings %
Top 10 Hldgs %
40.14%
Holding
105
New
12
Increased
40
Reduced
22
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Littelfuse
LFUS
|
+$33.6M |
| 2 |
Illumina
ILMN
|
+$30.2M |
| 3 |
Intuitive Surgical
ISRG
|
+$24.9M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$11.9M |
| 5 |
SiteOne Landscape Supply
SITE
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransUnion
TRU
|
+$44.1M |
| 2 |
Clarivate
CLVT
|
+$37.8M |
| 3 |
PTC
PTC
|
+$36.9M |
| 4 |
Netflix
NFLX
|
+$35.8M |
| 5 |
Keurig Dr Pepper
KDP
|
+$30.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.68% |
| 2 | Technology | 23.46% |
| 3 | Industrials | 21.92% |
| 4 | Financials | 5.64% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
76
Novo Nordisk
NVO
$209B
| $205K | 0.02% |
3,682
| – | – |
|
77
IQVIA
IQV
$39.3B
| $204K | 0.02% |
+940
| New | +$204K |
|
|
SPLK
78
DELISTED
Splunk Inc
SPLK
| $204K | 0.02% |
+2,310
| New | +$254K |
|
|
STAB
79
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $4K | ﹤0.01% |
13,570
| – | – |
|
|
NMTR
80
DELISTED
9 Meters Biopharma
NMTR
| $3K | ﹤0.01% |
500
| – | – |
|
81
Align Technology
ALGN
$12.3B
| – | – |
-493
| Closed | -$215K |
|
82
AptarGroup
ATR
$8.61B
| – | – |
-3,172
| Closed | -$373K |
|
83
Citigroup
C
$226B
| – | – |
-29,786
| Closed | -$1.59M |
|
|
84
Clarivate
CLVT
$1.16B
| – | – |
-2,252,621
| Closed | -$37.8M |
|
85
Charles River Laboratories
CRL
$12.8B
| – | – |
-809
| Closed | -$230K |
|
86
Essent Group
ESNT
$6.33B
| – | – |
-5,700
| Closed | -$235K |
|
87
iShares Core MSCI EAFE ETF
IEFA
$196B
| – | – |
-4,783
| Closed | -$332K |
|
88
Intuit
INTU
$89B
| – | – |
-497
| Closed | -$239K |
|
89
Matinas BioPharma
MTNB
$1.81M
| – | – |
-1,000
| Closed | -$40K |
|
|
90
Netflix
NFLX
$309B
| – | – |
-955,040
| Closed | -$35.8M |
|
91
Parker-Hannifin
PH
$135B
| – | – |
-721
| Closed | -$205K |
|
|
92
PTC
PTC
$16B
| – | – |
-342,265
| Closed | -$36.9M |
|
93
Atlassian
TEAM
$37.8B
| – | – |
-705
| Closed | -$207K |
|
|
94
TransUnion
TRU
$15.3B
| – | – |
-426,914
| Closed | -$44.1M |
|
95
UnitedHealth
UNH
$370B
| – | – |
-430
| Closed | -$219K |
|
|
DASTY
96
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| – | – |
-4,545
| Closed | -$224K |
|
Similar funds
FP
AC
BI
SFG
BONST
FFP
MI
OCAI
Sandhill Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Sandhill Capital Partners held 105 positions worth $935M, down 20% from $1.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Sandhill Capital Partners withdrew a net $65.1M in Q2 2022, closing 16 positions and reducing 22 holdings. Its most notable exit was TransUnion, an estimated $44.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
Against the trend, Sandhill Capital Partners opened a new position in Littelfuse worth $34M.
- Sandhill Capital Partners's largest Q2 2022 buy was Littelfuse: 133,807 shares worth $34M.
- Sandhill Capital Partners added most to JBT Marel in Q2 2022, an estimated $11.9M increase.
- Sandhill Capital Partners's biggest Q2 2022 reduction was Keurig Dr Pepper, cutting an estimated $30.8M.
- Sandhill Capital Partners fully exited TransUnion in Q2 2022, selling an estimated $44.1M.
- Sandhill Capital Partners's ten largest holdings make up 40% of its $935M portfolio in Q2 2022.
- Sandhill Capital Partners opened 12 new positions and closed 16 in Q2 2022.
- Sandhill Capital Partners's portfolio value fell 20% quarter-over-quarter to $935M.
Based on Sandhill Capital Partners's 13F filing for Q2 2022, filed 10 Aug 2022.